Literature DB >> 31881815

Silica Exposure and Scleroderma: More Bridges and Collaboration between Disciplines Are Needed.

Alain Lescoat1,2, Catherine Cavalin3,4,5, Alice Ballerie1,2, Valérie Lecureur1, Lucile Sesé6,7, Claire Cazalets2, Mathieu Lederlin2,8, Guillaume Coiffier9,10, Nicolas Belhomme2, Christophe Paris1,11, Ronan Garlantézec1,2, Stéphane Jouneau1,12, Patrick Jégo1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31881815      PMCID: PMC7124714          DOI: 10.1164/rccm.201911-2218LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
To the Editor: We have read with great interest Turner and colleagues’ correspondence concerning connective tissue disease (CTD) and silica exposure in artificial stone workers (1). We totally support their call for a new awareness on silica hazards and their broadening to CTD. Indeed, silica hazards are too often, and almost systematically, narrowed to silicosis (2). Although L. D. Erasmus was historically the first to link silica exposure with the occurrence of systemic sclerosis (SSc or scleroderma), B. Bramwell, a Scottish physician, had described an outbreak of scleroderma among stonemasons 50 years before (3). Despite this ancient association, SSc is still largely considered today to be of unknown cause. The Pasteurian paradigm (one cause, one disease) may have contributed to an oversimplified vision of causality in diseases, leading to a dichotomous vision of etiologies: either an obvious and single cause for some diseases (especially communicable diseases) or complex diseases with too many causal factors to be properly captured. Nonetheless, recent insights into the pathogenesis of SSc, including cancer-associated SSc, remind us that the search for a cause may not be totally in vain. Indeed, when silica exposure is properly explored (i.e., prospectively assessed through dedicated occupational questionnaires and/or evaluation by experts in occupational medicine and toxicology), this exposure appears to be strikingly frequent in male patients with SSc, with at least half of them having occupational silica exposure in recent European studies (4). Therefore, crystalline silica exposure may be a decisive cause or trigger, and this would be especially relevant in males, who are more often engaged in occupations involving silica. Interestingly, recent insights into the pathogenesis of silica-induced autoimmunity in mouse models have highlighted that the production of autoantibodies after silica exposure was significantly higher in males in comparison with female littermates (5). In humans, sex and gender in SSc may be especially crucial, as SSc is frequently more severe in men. The current outbreak of silicosis and CTD after exposure to high-silica-content artificial stone dusts both demonstrates the specificity of the association of crystalline silica with autoimmunity in comparison with other mineral dusts and reminds us that silica exposure does not only concern the mining industry but also covers a wider range of sectors. In this regard, the call for systematic screening of patients for CTDs after silica exposure appears central in patients both with and without signs of silicosis and/or pulmonary involvement. Concerning SSc, the systematic screening strategy proposed for a very early diagnosis of SSc (known as VEDOSS [Very Early Diagnosis of Systemic Sclerosis]) (6) may be especially relevant for these silica-exposed patients. This VEDOSS strategy does not only include testing for antinuclear antibodies but also emphasizes the central role of capillaroscopic findings and clinical detection of “puffy fingers,” a manifestation of SSc that may precede the occurrence of sclerodactyly. Such a screening would therefore imply a close collaboration of clinicians who have been trained to detect puffy fingers or other SSc early signs and who are familiar with capillaroscopic examinations with specialists of occupational diseases and silica-associated respiratory disorders likely to detect the situations of silica exposure. Beyond preventability and diagnosis, the lack of a proper understanding of the pathogenesis of silica-associated autoimmunity may also result from missing bridges between disciplines. From a toxicant viewpoint, this question of silica has been almost exclusively studied through fibrotic pulmonary diseases or cancer or, when addressing autoimmunity, has been based on mouse models of systemic lupus, whereas SSc has long been considered the CTD most frequently associated with silica exposure. The alarming recent outbreak of silica-associated CTD may provide an opportunity to fill this gap and offer a timely lever to collectively better understand the pathogenesis of SSc.
  5 in total

1.  The world is failing on silicosis.

Authors: 
Journal:  Lancet Respir Med       Date:  2019-03-11       Impact factor: 30.700

2.  Silica Exposure and Connective Tissue Disease: An Underrecognized Association in Three Australian Artificial Stone Workers.

Authors:  Marianne T Turner; Sameh R Samuel; Elizabeth J Silverstone; Deborah H Yates
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

3.  Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.

Authors:  J Avouac; J Fransen; U A Walker; V Riccieri; V Smith; C Muller; I Miniati; I H Tarner; S Bellando Randone; M Cutolo; Y Allanore; O Distler; G Valentini; L Czirjak; U Müller-Ladner; D E Furst; A Tyndall; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2010-11-15       Impact factor: 19.103

4.  High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis.

Authors:  Evelien De Decker; Marie Vanthuyne; Daniel Blockmans; Frederic Houssiau; Jan Lenaerts; Rene Westhovens; Benoit Nemery; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2018-02-23       Impact factor: 2.980

5.  Silicosis and Silica-Induced Autoimmunity in the Diversity Outbred Mouse.

Authors:  Jessica M Mayeux; Gabriela M Escalante; Joseph M Christy; Rahul D Pawar; Dwight H Kono; Kenneth M Pollard
Journal:  Front Immunol       Date:  2018-04-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.